Evidence map›Paper›PMID 29242607›Full record

ArticleOncogene2018

The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.

Tomokatsu Omoto, Joo-Ri Kim-Kaneyama, Xiao-Feng Lei, Akira Orimo, Koji Ohnishi, Kosuke Yoshihara, Aya Miyauchi, Shuo Li, Lin Gao, Takahiro Umemoto and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Cancer-associated fibroblasts in carcinogenesis.Journal of translational medicine · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Physiological and pathological roles of Hic‑5 in several organs (Review).International journal of molecular medicine · 2022
    Review
  8. Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer.International journal of molecular sciences · 2022
    Review
  9. Bioinformatics Profiling and Experimental Validation of 4 Differentially-Expressed LIM Genes in the Course of Colorectal-Adenoma-Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Tomokatsu OmotoDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Joo-Ri Kim-KaneyamaDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan. shuri@pharm.showa-u.ac.jp.
Xiao-Feng LeiDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Akira OrimoDepartment of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Koji OhnishiDepartment of Cell Pathology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kosuke YoshiharaDepartment of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Aya MiyauchiDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Shuo LiDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Lin GaoDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Takahiro UmemotoDepartment of Gastroenterological and General Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Junichi TanakaDepartment of Gastroenterological and General Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Kenta NakaharaDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama, Japan.
Motohiro TakeyaDepartment of Cell Pathology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Fumio IshidaDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama, Japan.
Shin-Ei KudoDigestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama, Japan.
Shogo HaraguchiDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Takuro MiyazakiDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Akira MiyazakiDepartment of Biochemistry, Showa University School of Medicine, Tokyo, Japan.
Showa University · JPShowa University Northern Yokohama Hospital · JPKumamoto University · JPShowa University Fujigaoka Hospital · JPJuntendo University · JPNiigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinoma-associated fibroblasts (CAFs) influence tumor initiation, progression, and metastasis within the tumor-associated stroma. This suggests that CAFs would be a potential target for tumor therapy. Here we found that Hydrogen peroxide-inducible clone-5 (Hic-5), also named transforming growth factor beta-1-induced transcript 1 protein (Tgfb1i1), was strongly induced in CAFs found in human colorectal cancer. To investigate the role of Hic-5 in CAFs, we isolated CAFs and the control counterpart normal fibroblasts (NFs) from human colorectal cancer and non-cancerous regions, respectively. Hic-5 was highly expressed in isolated human CAFs and strongly induced in NFs in culture by the supernatant from cultured colorectal cancer cells as well as cytokines such as TGF-β, IL-1β and stromal cell-derived factor 1 (SDF-1/CXCL12). Furthermore, tumor growth was inhibited in a co-culture assay with Hic-5 knockdown fibroblasts compared with control fibroblasts. To clarify the function and significance of Hic-5 in colorectal cancer in vivo, we utilized a mouse model of azoxymethane (AOM)-induced colorectal cancer using Hic-5-deficient mice. Lack of Hic-5 in CAFs completely prevented AOM-induced colorectal cancer development in the colon tissues of mice. Mechanistic investigation revealed that Hic-5 promoted the expression of lysyl oxidase and collagen I in human control counterpart fibroblasts. Taken together, these results demonstrate that Hic-5 in CAFs is responsible for orchestrating or generating a tumor-promoting stroma.

Indexed as

AnimalsApoptosisAzoxymethaneBiomarkers, TumorCancer-Associated FibroblastsCarcinogenesisCell ProliferationCoculture TechniquesColorectal NeoplasmsCytoskeletal ProteinsDNA-Binding ProteinsFibroblastsHumansIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMaleAzoxymethaneBiomarkers, TumorCytoskeletal ProteinsDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsLOX protein, humanProtein-Lysine 6-OxidaseTGFB1I1 protein, humanTgfb1i1 protein, mouse

Identifiers

PMID29242607
OpenAlexW2772992603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.